Myofascial Pain Syndrome after Head and Neck Cancer Treatment: Prevalence, Risk Factors and  Influence on Quality of Life    Leticia Rodrigues Cardoso, MSc1; Cláudia Carvalho Rizzo, MD, PhD2; Cleyton Zanardo de Oliveira,  MSc3; Carlos Roberto dos Santos, MD4; André Lopes Carvalho, MD, PhD4    Affiliations:  1. Physical Therapy Department, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil  2. Anesthesiology Department, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil  3. Biostatistics Department, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil  4. Head and Neck Surgery Department, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil    Funding: This work was funded by an Internal Institutional grant from Barretos Cancer Hospital.     Acknowledgements:  We  would  like  to  acknowledge  the  Teaching  and  Research  Institute  of  the  Barretos Cancer Hospital, notably the Centre for Researcher Support, the Post‐Graduate Secretariat  and the librarians for support and help in the development of this study.    Corresponding Author: Leticia Rodrigues Cardoso, MSc, Physical Therapy Department, Barretos  Cancer Hospital, Barretos, Sao Paulo, Brazil, Antenor Duarte Villela Street, n 1331, Zip Code 14784‐ 400 ([email protected])    Running Title: Myofascial Pain Syndrome after Head and Neck Cancer Treatment    Keywords: head and neck cancer, pain, myofascial pain, physiotherapy, quality of life.         

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to   differences between this version and the Version of Record. Please cite this article as an ‘Accepted Article’, doi: 10.1002/hed.23825

Abstract    Background:  Patients  undergoing  treatment  for  head  and  neck  cancer  (HNC)  might  develop  myofascial  pain  syndrome  (MPS)  as  sequelae.  The  aim  of  this  study  was  to  determine  the  prevalence,  risk  factors  and  quality  of  life  related  to  MPS.  Methods:  This  is  a  prospective  study  including  HNC  patients  with  at  least  one  year  disease  free  interval.  Results:  167  patients  were  analysed, MPS was diagnosed in 20 (11.9 %). In the multivariate analysis, hypopharynx tumors (OR =  6.35; 95% CI [1.58; 25.56]) and neck dissection (OR = 3.43; 95% CI [1.16; 10.17]) were independent  factors for MPS. The pain (p

Myofascial pain syndrome after head and neck cancer treatment: Prevalence, risk factors, and influence on quality of life.

Patients undergoing treatment for head and neck cancer may develop myofascial pain syndrome as sequelae. The purpose of this study was to determine th...
514KB Sizes 2 Downloads 3 Views